Management of uncomplicated malaria in private health facilities in North-West Ethiopia: a clinical audit of current practices

Table 5 Anti-malarial prescription with major error classifications, West Gojjam, Oct 2016 – Jan 2017

Description	Major error Treatment
	Major Error (CQ for Presumed Malaria Or Monotherapy with Arthem injection for Pf or Pv or mixed malaria cases)
	Illegible			Actual practices
	Both PPM + NPPM	PPM	NPPM	Both PPM + NPPM	PPM	NPPM
Microscopy (n = 252)
P. falciparum	117	63	54	52	33^a	19^a
Mixed (Pf &Pv)	38	23	15	0	0	0
Presumed^d	30	12	18	19	7^b	12^b
P. vivax	67	34	33	2	2^a	0
Sub total	252	132	120	73	42	31
Percentage				28.9	31.8	25.8
RDTs (n = 78)
P. falciparum	26	16	10	13	7^a	6^a
Mixed (Pf &Pv or Pf)	11	7	4	0	0	0
Presumed^d	26	14	12	13	9^b	4^b
P. vivax	15	11	4	3	3^a	0
Sub total	78	48	30	29	19	10
Percentage				37.2	39.6	33.3
Grand total	330	180	150	102	61	41
Percentage				30.9	33.9^c	27.3^c

The table depicts the frequency of records of antimalarial drug prescription in 11 medium clinics in the West Gojjam Zone, Amhara. The table presents the magnitude of major errors by partnership status
^a70 Pf or Pv malaria patients were treated with only Arthem Injection;
^b 32 ^dPresumed malaria patients were treated with CQ;
^cThe X² statistic is 1.16. The p-value is 0.28. This result is not significant at p < .05; Major Error Treatment

ISSN: 1472-6963